Therefore, in the absence of diffuse gastric cancer, germline genetic testing for CDH1 mutations is recommended for individuals in the setting of early-onset ILC (age < 45 years), bilateral ILC (age <70 years), or extensive family history of ILC1,2,8. The gene discussed is CDH1; the disease is Familial gastric cancer.